Koers Gwo Xi Stem Cell Applied Technology Co. , Ltd
Aandelen
6704
TW0006704000
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
38,65 TWD | +0,39% | +13,18% | +6,47% |
Omzet 2022 | 181 mln. 5,62 mln. 5,16 mln. | Omzet 2023 | 141 mln. 4,39 mln. 4,03 mln. | Marktkapitalisatie | 3,48 mld. 108 mln. 99,49 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -112 mln. -3,48 mln. -3,2 mln. | Nettowinst (verlies) 2023 | -88 mln. -2,74 mln. -2,51 mln. | EV/omzet 2022 * | - |
Nettoschuld 2022 | 358 mln. 11,13 mln. 10,23 mln. | Nettoschuld 2023 | 14,55 mln. 452K 416K | EV/omzet 2023 | 24,8 x |
K/w-verhouding 2022 * |
-
| K/w-verhouding 2023 |
-37
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 99% |
1 dag | +0,39% | ||
1 week | +13,18% | ||
Lopende maand | +24,28% | ||
1 maand | +25,69% | ||
3 maanden | +16,59% | ||
6 maanden | +7,51% | ||
Lopend jaar | +6,47% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ming Hsi Chuang
CEO | Chief Executive Officer | - | 01-07-13 |
Pang Yu Li
DFI | Director of Finance/CFO | - | 01-06-21 |
Po Cheng Lin
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Li Hsing Ho
BRD | Director/Board Member | - | 29-06-22 |
Nuan Hsuan Ho
BRD | Director/Board Member | - | 29-06-22 |
Ming Hsi Chuang
CEO | Chief Executive Officer | - | 01-07-13 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
17-05-24 | 38,65 | +0,39% | 566 743 |
16-05-24 | 38,5 | +0,65% | 637 155 |
15-05-24 | 38,25 | +2,41% | 682 637 |
14-05-24 | 37,35 | +9,37% | 1 054 597 |
13-05-24 | 34,15 | 0,00% | 97 113 |
slotkoers Taipei Exchange, 17 mei 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+6,47% | 115 mln. | |
+32,09% | 693 mld. | |
+29,39% | 584 mld. | |
-1,34% | 372 mld. | |
+20,34% | 332 mld. | |
+7,39% | 294 mld. | |
+14,25% | 239 mld. | |
-3,03% | 211 mld. | |
+10,02% | 210 mld. | |
+8,49% | 168 mld. |